Type I and type III ROP16 overexpression primary lung adenocarcinoma cells expressed increased p-STAT3 compared to that of the control (p < .01), but this was not observed in type II ROP16 overexpression group (p > .05) (Figure 8c). This evidence concerns the gene STAT3 and lung adenocarcinoma.